Svahn Adam J, Becker Thomas S, Graeber Manuel B
Developmental Neurobiology Laboratory, University of Sydney, Sydney, NSW, Australia.
Brain Pathol. 2014 Nov;24(6):665-70. doi: 10.1111/bpa.12195.
More than 80 years ago, Pio Del Rio-Hortega recognized that one of the "main controversial points in regard to the microglia" is "whether it belongs to the reticulo-endothelial system [i.e. monocytes and macrophages] and possesses the ordinary characteristics of this system or has a more specialized function." The notion of microglia having functions that are different from those of other macrophages has gained significant support in recent years. The brain represents a unique environment and shows species, developmental and regional specialization. Thus, any consideration of microglial activity has to be thought of in this tissue context. Contexts may be normal (health, physiology) or disease conditions showing either primary or secondary microglial involvement. Subclinical, reversible "soft pathologies" (Kreutzberg) such as pain that involves microglia also exist. Here, we examine a multilayered approach to understanding microglia that illustrates the emergent character of the microglial (population) phenotype. Accordingly, terms such as microglial "activation" and microgliosis, which are of increasing importance for our understanding of neurological disorders, need to be filled with refined meaning. It is suggested that the pathophysiological context guides nomenclatorial considerations; for example, development, trauma or pain-associated microglia is preferred over the traditional but less distinctive "microglial activation." This should also help to tease out the different functional subtypes currently hidden under the umbrella term "neuroinflammation," which is being applied so widely that it has become effectively useless in practice and even inhibits research progress because both true and pseudo-inflammation are covered by this term.
80多年前,皮奥·德尔·里奥-奥尔特加就认识到,“关于小胶质细胞的主要争议点之一”是“它是否属于网状内皮系统(即单核细胞和巨噬细胞)并具有该系统的一般特征,还是具有更特殊的功能”。近年来,小胶质细胞具有与其他巨噬细胞不同功能的观点得到了大量支持。大脑代表着一个独特的环境,具有物种、发育和区域特异性。因此,任何关于小胶质细胞活性的考量都必须放在这个组织背景中去思考。背景情况可能是正常的(健康、生理状态),也可能是显示原发性或继发性小胶质细胞参与的疾病状态。还存在一些亚临床、可逆的“软性病变”(克洛伊茨贝格),比如涉及小胶质细胞的疼痛。在这里,我们研究一种理解小胶质细胞的多层方法,该方法阐释了小胶质细胞(群体)表型的涌现特征。因此,对于我们理解神经疾病越来越重要的诸如小胶质细胞“激活”和小胶质细胞增生等术语,需要赋予更精确的含义。建议病理生理背景指导命名方面的考量;例如,相较于传统但辨识度较低的“小胶质细胞激活”,发育、创伤或疼痛相关的小胶质细胞这种说法更可取。这也应有助于梳理出目前隐藏在“神经炎症”这一宽泛术语下的不同功能亚型,该术语应用如此广泛,以至于在实际应用中已变得毫无用处,甚至因为它涵盖了真正的炎症和假性炎症而阻碍了研究进展。